Activity Provided By:

Relias LLC

Updates in the Diagnosis and Treatment of Castleman Disease: Expert Perspectives

Overview / Abstract:	Target Audience This activity has been designed to address the educational needs of community and academic physicians specializing in hematology and hematology/oncology. It will also benefit other clinicians who manage patients with Castleman disease (CD). Program Overview This activity will cover the latest updates in diagnosing and treating Castleman disease. Learning Objectives Upon completion of this activity, participants should be able to: Identify patients with CD Determine evidence-based treatment for CD in alignment with current guidelines
Expiration	Dec 22, 2021
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1.0
Accreditation	ACCME
Presenters / Authors / Faculty	David C. Fajgenbaum, MD, MBA, MSc Assistant Professor of Medicine Division of Translational Medicine and Human Genetics University of Pennsylvania Associate Director, Patient Impact Penn Orphan Disease Center Founding Director Center for Cytokine Storm Treatment & Laboratory Co-Founder and Executive Director Castleman Disease Collaborative Network Philadelphia, PA Sudipto Mukherjee, MD, PhD, MPH Assistant Professor of Medicine Lerner College of Medicine at CWRU Director of Rare Cancers and Blood Diseases Program Department of Hematology and Medical Oncology Leukemia Program Taussig Cancer Institute Cleveland Clinic Cleveland, OH
Sponsors / Supporters / Grant Providers	This activity is supported by an educational grant from EUSA Pharma.
Keywords / Search Terms	Relias LLC Hematology-Oncology, Oncology, Primary Care Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map